UNSPSC 51283921: Sulfametomidine or sulfamethomidine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C12H14N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 940ZL3AHKB, chemically known as sulfanilamide, n(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)- but generally known as sulfamethomidine, which bears US NIH Compound Identifier 19596. European Medicines Agency schedules Sulfametomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10713MIG.

UNSPSC 51283921 Sulfametomidine or sulfamethomidine is a Commodity code that in recent state and local procurement activity covers pharmaceutical products supplied through cooperative purchasing agreements and direct government procurement channels. The recent opportunities posted under this code do not align with the nominal code scope — the Illinois Department of Public Health's August 2026 piggyback pharmaceutical contract through the MMCAP Infuse consortium awarded to Chartwell Rx LLC named Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets as the actual products supplied, while a Seminole County, Florida IFB released June 2026 sought Naloxone and Safe Drug Deactivation Systems. State and local health departments and county public health authorities are the primary issuing bodies under this code, procuring through competitive bidding (IFB) and cooperative purchasing vehicles. The Illinois contract totaled $2,999,999.11 over 12 months with renewal options for years 2 and 3, awarded on a lowest-priced responsive and responsible basis with no set-asides applied.

Activity appears concentrated in Florida and Illinois based on the recent record. The Illinois Department of Public Health's MMCAP Infuse piggyback contract (Bid Number 26-482DPH-PREPD-B-53392, awarded August 28, 2026) and Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2026) represent the two identifiable recent opportunities; neither directly solicits the sulfametomidine or sulfamethomidine specified by the code's name. Seminole County's procurement required 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems delivered annually in quarterly shipments, with vendor responsibility for all shipping and delivery costs. The mismatch between the code's nominal scope and the actual pharmaceutical products being procured through these opportunities suggests limited aligned activity for this specific drug classification in current state and local pipeline activity.